Key result
Elderly Brugada syndrome linked to ~53% lower annual cardiac event risk vs. nonelderly patients.
Why the study?
The risk stratification of elderly patients with Brugada syndrome for life-threatening arrhythmias remains unclear.
Cohort (n=523)
Yes
Elderly patients with Brugada syndrome have a lower risk of life-threatening arrhythmias compared to nonelderly patients, with a history of VF being the primary predictor of future cardiac events, while asymptomatic elderly patients have a negligible risk.
May support tailored risk assessment favoring observation in asymptomatic elderly Brugada patients; extends age-stratified observational data but requires prospective validation.
Background Brugada syndrome (BrS) is an inherited cardiac channelopathy associated with a high risk of sudden cardiac death (SCD) due to ventricular fibrillation (VF). Although implantable cardioverter‐defibrillators (ICDs) are the primary therapy for SCD prevention, the risk stratification of elderly patients with BrS remains unclear. This study aimed to evaluate the incidence and risk factors of life‐threatening arrhythmias in elderly patients with BrS. Methods We analyzed 523 patients with BrS (mean age 51 ± 13 years, 497 men) enrolled in the multicenter prospective Japan Idiopathic Ventricular Fibrillation Study. Patients were categorized into the elderly (>60 years, n = 150) and nonelderly (≤60 years, n = 373) groups. Clinical characteristics, programmed electrical stimulation (PES) results, and outcomes, including cardiac events (CEs: VF, fast ventricular tachycardia, or SCD), were compared. Statistical analyses were performed using Kaplan–Meier curves and Cox proportional hazard models. Results During a mean follow‐up of 106 ± 62 months, 59 patients (11%) experienced CE. The annual CE incidence was lower in the elderly group than in the nonelderly group (0.7% vs. 1.5%, p = 0.016). History of VF independently predicted CE occurrence in elderly patients (hazard ratio: 23.5, p < 0.001). Asymptomatic elderly patients exhibited a negligible risk of CE. PES did not predict CE occurrence in the elderly group. Conclusions Elderly patients with BrS have a better prognosis than nonelderly patients, particularly if they are asymptomatic. A history of VF is a key risk factor for life‐threatening arrhythmias in elderly patients with BrS.
No takes yet. Share an insight, caveat, or question.
Shinohara et al. (2025) conducted a cohort in Brugada syndrome (n=523). Elderly age (>60 years) vs. Nonelderly age (≤60 years) was evaluated on Cardiac events (ventricular fibrillation, fast ventricular tachycardia, or sudden cardiac death) (p=0.016). Elderly patients with Brugada syndrome had a significantly lower annual incidence of cardiac events compared to nonelderly patients (0.7% vs. 1.5%), with a history of ventricular fibrillation being a strong independent predictor of events in the elderly.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: